Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,922 | -19.7% | 15,582 | 0.0% | 0.00% | – |
| Q2 2023 | $105,802 | +31.1% | 15,582 | -3.3% | 0.00% | – |
| Q1 2023 | $80,731 | +2.7% | 16,114 | 0.0% | 0.00% | – |
| Q4 2022 | $78,636 | -63.0% | 16,114 | +9.3% | 0.00% | – |
| Q3 2022 | $212,594 | -6.8% | 14,743 | -2.2% | 0.00% | – |
| Q2 2022 | $228,085 | +25.4% | 15,075 | -1.6% | 0.00% | – |
| Q1 2022 | $181,942 | -41.7% | 15,315 | -20.3% | 0.00% | – |
| Q4 2021 | $312,000 | -42.0% | 19,220 | +1.9% | 0.00% | – |
| Q3 2021 | $538,000 | -21.2% | 18,856 | -6.6% | 0.00% | -100.0% |
| Q2 2021 | $683,000 | +27.0% | 20,197 | +13.6% | 0.00% | – |
| Q1 2021 | $538,000 | -41.5% | 17,785 | -4.2% | 0.00% | -100.0% |
| Q4 2020 | $920,000 | +34.3% | 18,573 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $685,000 | -17.3% | 17,840 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $828,000 | +106.5% | 18,127 | +18.1% | 0.00% | – |
| Q1 2020 | $401,000 | -0.2% | 15,353 | +19.3% | 0.00% | – |
| Q4 2019 | $402,000 | +15.9% | 12,868 | -4.4% | 0.00% | – |
| Q3 2019 | $347,000 | +16.1% | 13,467 | +2.9% | 0.00% | – |
| Q2 2019 | $299,000 | – | 13,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |